NovoMix 30 is a biphasic insulin which contains 30% soluble insulin aspart. This has a rapid onset of action, and NovoMix 30 should thus be given closer to a meal than biphasic human insulin. The crystalline phase in NovoMix 30 is 70% insulin aspart protamine, which has an activity profile similar to that of human isophane (NPH) insulin.
The onset of action of NovoMix 30 occurs within 10-20 minutes of subcutaneous injection. The maximum effect is exerted between 1 and 4 hours after injection. The duration of action of NovoMix 30 is up to 24 hours.
1 ml of the suspension contains 100 units soluble insulin aspart*/protamine-crystallised insulin aspart* in the ratio 30/70 (equivalent to 3.5 mg).
1 cartridge contains 3 ml equivalent to 300 units.